The purpose of this study was to examine whether phosphorylated (p)Y397-FAK expression levels in the endothelium of breast cancer before treatment are associated with response to anthracycline-based combination neoadjuvant chemotherapy and the subsequent risk of relapse. This evidence concerns the gene PTK2 and breast cancer.